8 April 2020 - A South Canterbury cancer patient is anticipating an easier treatment regime with Revlimid, which has now been subsidised by PHARMAC.
Emma Holden (32) was diagnosed with the incurable blood cancer, multiple myeloma two years ago, and says this new treatment is the best news she’s had in more than a year.
“It’s a game changer for me.”